Want to see AU:NRZ full AI Analyst Report?
Top Page
NeuRizer Ltd
(Sydney:NRZ)
Select Model
Select Model
Rating:38Underperform
Price Target:―
Action:N/A
Date:04/08/25
The overall stock score for NeuRizer Ltd is primarily impacted by its poor financial performance, characterized by persistent losses and negative cash flows. The lack of technical analysis data and unfavorable valuation metrics further contribute to a low score. Despite a stable balance sheet with low leverage, the company's inability to achieve profitability and generate positive cash flows poses significant risks to its financial health and attractiveness to investors.
Positive Factors
Strategic Location and Technology
The strategic location and advanced technology of the NeuRizer Urea Project enable cost-effective production and distribution, providing a competitive edge in the fertilizer market.
Negative Factors
Persistent Financial Losses
Ongoing financial losses and negative cash flows indicate operational inefficiencies and hinder the company's ability to invest in growth or return value to shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Location and Technology
The strategic location and advanced technology of the NeuRizer Urea Project enable cost-effective production and distribution, providing a competitive edge in the fertilizer market.
Read all positive factors
NeuRizer Ltd (NRZ) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$3.36M
Dividend YieldN/A
Average Volume (3M)10.00M
Price to Earnings (P/E)―
Beta (1Y)0.96
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees10
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,369,758,300
10 Day Avg. Volume9,997,589
30 Day Avg. Volume9,997,589
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.25
Price to Sales (P/S)0.00
P/FCF Ratio-3.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$568.50M
NeuRizer Ltd Business Overview & Revenue Model
Company Description
NeuRizer Ltd. (NRZ.AX) is an Australian company primarily focused on the sustainable production of carbon-neutral fertilizers. Through its key initiative, the NeuRizer Urea project, the company supplies nitrogen-based agricultural inputs to farmer...
How the Company Makes Money
NeuRizer Ltd generates revenue primarily through the sale of urea, a key agricultural fertilizer, produced at its NeuRizer Urea Project. The company capitalizes on its strategic location, advanced technology, and integration capabilities to ensure...
NeuRizer Ltd Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -31.45K | -45.39K | -159.00K | -180.00K | -77.68K |
| EBITDA | -4.48M | -12.55M | -12.29M | -8.68M | -6.92M |
| Net Income | -5.60M | -16.26M | -20.40M | -13.57M | -7.16M |
Balance Sheet | |||||
| Total Assets | 129.32M | 128.67M | 91.61M | 55.18M | 35.93M |
| Cash, Cash Equivalents and Short-Term Investments | 568.72K | 1.21M | 1.07M | 22.81M | 6.81M |
| Total Debt | 2.11M | 2.44M | 321.77K | 224.84K | 822.07K |
| Total Liabilities | 56.30M | 55.91M | 35.12M | 3.88M | 1.78M |
| Stockholders Equity | 73.02M | 72.75M | 56.49M | 51.30M | 34.16M |
Cash Flow | |||||
| Free Cash Flow | -6.09M | -34.32M | -16.47M | -8.27M | -1.86M |
| Operating Cash Flow | -3.56M | -9.05M | -10.23M | -4.61M | 904.92K |
| Investing Cash Flow | 826.61K | -16.11M | -27.63M | -3.14M | -2.76M |
| Financing Cash Flow | 2.09M | 25.92M | 15.49M | 23.75M | 6.38M |
NeuRizer Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | AU$2.04M | -2.08 | -7.89% | ― | ― | 70.89% | |
42 Neutral | AU$2.48M | -0.67 | -109.35% | ― | ― | 23.08% | |
39 Underperform | AU$2.92M | -0.43 | -119.29% | ― | ― | 31.82% | |
38 Underperform | AU$3.36M | -0.26 | -7.69% | ― | ― | ― |
* Basic Materials Sector Average
AU:NRZ
NeuRizer Ltd
0.01
0.00
0.00%
AU:BLZ
Blaze Minerals
―
―
―
AU:PNT
Panther Metals Ltd.
0.01
0.00
0.00%
AU:LRD
Lord Resources Limited
0.01
>-0.01
-36.36%
NeuRizer Ltd Corporate Events
NeuRizer Ltd Faces ASX Suspension Over Reporting Delay
Mar 16, 2025
NeuRizer Ltd, along with several other companies, has been suspended from quotation on the ASX due to not lodging the required periodic report by the due date. This suspension may impact the company’s market operations and investor confidenc...
NeuRizer Ltd Announces New Securities Quotation on ASX
Feb 21, 2025
NeuRizer Ltd has announced the quotation of 133,333,333 ordinary fully paid securities on the ASX, marking a significant step in their financial strategy. This move could enhance the company’s market presence and provide additional capital f...
NeuRizer Announces Planned Issuance of 133 Million Securities
Feb 17, 2025
NeuRizer Ltd has announced a proposed issuance of 133,333,333 ordinary fully paid securities. The issuance is scheduled for February 20, 2025, with the intention of having these securities quoted on the ASX, subject to approval. This move could po...
NeuRizer Ltd Completes $200K Private Share Placement
Feb 17, 2025
NeuRizer Ltd has successfully completed a private share placement to raise $200,000 through the issuance of 133,333,333 new fully paid ordinary shares at $0.0015 per share. The funds raised will be used for general working capital, specifically to...
NeuRizer Ltd Issues 78 Million Unquoted Equity Securities
Feb 11, 2025
NeuRizer Ltd has announced the issuance of 78,000,000 unquoted equity securities, specifically options expiring on May 29, 2028. This move is part of its employee incentive scheme, which reflects the company’s ongoing efforts to incentivize ...
NeuRizer Ltd Announces Quotation of 159.8 Million New Securities
Feb 7, 2025
NeuRizer Ltd, a company listed on the ASX under the code NRZ, has announced the quotation of 159,800,000 ordinary fully paid securities as of February 7, 2025, as part of previously announced transactions. This move potentially impacts the company...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.